| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF611 ZNF76 NR1H3 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 ZNF394 ZNF154 USP3 ZNF460 ZFP82 ZNF436 ZSCAN18 | 6.33e-11 | 1459 | 27 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF611 ZNF76 NR1H3 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZSCAN18 | 6.14e-10 | 1412 | 27 | 14 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF611 ZNF76 NR1H3 IKZF1 ZNF600 ZNF860 ZSCAN16 ZNF394 ZNF154 USP3 ZNF460 ZFP82 ZSCAN18 | 1.77e-09 | 1244 | 27 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF611 ZNF76 NR1H3 IKZF1 ZNF600 ZNF860 ZSCAN16 ZNF394 ZNF154 USP3 ZNF460 ZFP82 ZSCAN18 | 2.29e-09 | 1271 | 27 | 13 | GO:0000987 |
| Domain | Znf_C2H2-like | ZNF611 ZNF76 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 USP39 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZNF222 ZSCAN18 | 1.22e-14 | 796 | 26 | 15 | IPR015880 |
| Domain | Znf_C2H2 | ZNF611 ZNF76 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 USP39 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZNF222 ZSCAN18 | 1.44e-14 | 805 | 26 | 15 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF611 ZNF76 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 USP39 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZNF222 ZSCAN18 | 1.52e-14 | 808 | 26 | 15 | SM00355 |
| Domain | - | ZNF611 ZNF76 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZNF222 ZSCAN18 | 3.98e-14 | 679 | 26 | 14 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF611 ZNF76 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZNF222 ZSCAN18 | 5.37e-14 | 694 | 26 | 14 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF611 ZNF76 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZNF222 ZSCAN18 | 2.43e-13 | 775 | 26 | 14 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF611 ZNF76 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZNF222 ZSCAN18 | 2.52e-13 | 777 | 26 | 14 | PS00028 |
| Domain | zf-C2H2 | ZNF611 ZNF76 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZNF222 | 1.51e-12 | 693 | 26 | 13 | PF00096 |
| Domain | KRAB | 1.95e-08 | 358 | 26 | 8 | PS50805 | |
| Domain | KRAB | 1.95e-08 | 358 | 26 | 8 | PF01352 | |
| Domain | KRAB | 2.46e-08 | 369 | 26 | 8 | SM00349 | |
| Domain | KRAB | 2.52e-08 | 370 | 26 | 8 | IPR001909 | |
| Domain | SCAN | 6.32e-05 | 56 | 26 | 3 | SM00431 | |
| Domain | zf-C2H2_6 | 6.40e-05 | 314 | 26 | 5 | PF13912 | |
| Domain | SCAN_BOX | 7.02e-05 | 58 | 26 | 3 | PS50804 | |
| Domain | SCAN | 7.02e-05 | 58 | 26 | 3 | PF02023 | |
| Domain | SCAN_dom | 7.02e-05 | 58 | 26 | 3 | IPR003309 | |
| Domain | Retrov_capsid_C | 7.39e-05 | 59 | 26 | 3 | IPR008916 | |
| Domain | ZnF_UBP | 1.02e-04 | 11 | 26 | 2 | SM00290 | |
| Domain | zf-UBP | 1.68e-04 | 14 | 26 | 2 | PF02148 | |
| Domain | ZF_UBP | 1.68e-04 | 14 | 26 | 2 | PS50271 | |
| Domain | Znf_UBP | 1.68e-04 | 14 | 26 | 2 | IPR001607 | |
| Domain | USP_1 | 4.25e-03 | 70 | 26 | 2 | PS00972 | |
| Domain | UCH | 4.37e-03 | 71 | 26 | 2 | PF00443 | |
| Domain | USP_2 | 4.37e-03 | 71 | 26 | 2 | PS00973 | |
| Domain | USP_dom | 4.49e-03 | 72 | 26 | 2 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 4.49e-03 | 72 | 26 | 2 | IPR001394 | |
| Domain | USP_3 | 4.49e-03 | 72 | 26 | 2 | PS50235 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF611 NR1H3 ZNF600 ZNF860 ZNF394 ZNF154 ZNF460 ZNF436 ZNF222 | 1.28e-04 | 1387 | 22 | 9 | M734 |
| Pubmed | 7.84e-05 | 17 | 27 | 2 | 7557990 | ||
| Pubmed | 1.53e-04 | 1084 | 27 | 6 | 11544199 | ||
| Pubmed | 1.59e-04 | 24 | 27 | 2 | 31911859 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 2.68e-04 | 1203 | 27 | 6 | 29180619 | |
| Pubmed | 3.70e-04 | 181 | 27 | 3 | 37372979 | ||
| Interaction | ZNF142 interactions | 2.50e-06 | 21 | 26 | 3 | int:ZNF142 | |
| Interaction | ZSCAN32 interactions | 2.61e-05 | 45 | 26 | 3 | int:ZSCAN32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.40e-06 | 1192 | 27 | 7 | chr19q13 | |
| Cytoband | 2p11.2 | 6.57e-04 | 64 | 27 | 2 | 2p11.2 | |
| Cytoband | 19q13.41 | 9.73e-04 | 78 | 27 | 2 | 19q13.41 | |
| Cytoband | 19q13.4 | 9.98e-04 | 79 | 27 | 2 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 6.97e-03 | 213 | 27 | 2 | chr2p11 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF611 ZNF76 IKZF1 ZNF600 ZNF142 ZNF860 ZSCAN16 ZNF394 ZNF154 ZNF460 ZFP82 ZNF436 ZNF222 ZSCAN18 | 6.37e-14 | 718 | 25 | 14 | 28 |
| GeneFamily | Ubiquitin specific peptidases | 2.70e-03 | 56 | 25 | 2 | 366 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.52e-05 | 142 | 27 | 3 | 5690eee2ce1ecd02e34eac4193578bd13c4228b9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-04 | 159 | 27 | 3 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 168 | 27 | 3 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-04 | 174 | 27 | 3 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | mild-B_cell|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-04 | 183 | 27 | 3 | 175aaf8fbbff52eab87d78a49d5ab02cd489c438 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-04 | 183 | 27 | 3 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-04 | 184 | 27 | 3 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.89e-04 | 186 | 27 | 3 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-04 | 186 | 27 | 3 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-04 | 186 | 27 | 3 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | URO-Lymphocyte-B-B_naive|URO / Disease, Lineage and Cell Type | 1.92e-04 | 187 | 27 | 3 | 9ed6a39aae7126ddbd01aec3376113b6b4517383 | |
| ToppCell | Int-URO-Lymphocyte-B|Int-URO / Disease, Lineage and Cell Type | 1.95e-04 | 188 | 27 | 3 | 956568df5c4b26089b46673c30dd9a6e9581b0c9 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.95e-04 | 188 | 27 | 3 | f7dd01084ad14d2a2d8adf552e811b84eebf5514 | |
| ToppCell | severe_COVID-19-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.04e-04 | 191 | 27 | 3 | 55a282478488efd1561ea57a6f0218f55f711bb0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-04 | 191 | 27 | 3 | fda432a7f79664e8ffd5d03c1c69ec43bbac994b | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|World / disease group, cell group and cell class | 2.08e-04 | 192 | 27 | 3 | 3352f13a6e706991dcf3ec173587bb6aba36a385 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 192 | 27 | 3 | ac507fd7cf3b3e521a15ef03bb4e81eb23807985 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 192 | 27 | 3 | 24f40dadec04f4f99c31000fa9f09d07148fa190 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 192 | 27 | 3 | 71e04e197825856c6d4278fc76c58ab17ffa2387 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 192 | 27 | 3 | 78546a6e077076834fd717607610ab6df3b6e7ba | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.11e-04 | 193 | 27 | 3 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Healthy/Control-CD4+_T_naive|World / Disease group and Cell class | 2.11e-04 | 193 | 27 | 3 | 6218e6cbe44d92bb98d42ef2f5e18ab7a683b100 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.11e-04 | 193 | 27 | 3 | 792315f409a57fa6a8a88c850060b1e089e062ea | |
| ToppCell | severe_COVID-19-CD4+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.14e-04 | 194 | 27 | 3 | 4b86f3cc173ea779399d5b3598b45b25f60a4395 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 194 | 27 | 3 | d429bb5e422a07bd92f0dc48cd51528e8b7d9a72 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 194 | 27 | 3 | bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 194 | 27 | 3 | 408dfc7060095972a54ae37ae8105521df6fbbee | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 195 | 27 | 3 | 8d286622f86c844d1b06a106ee4a3f813eba05bb | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.17e-04 | 195 | 27 | 3 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 195 | 27 | 3 | 4193e58788e90c3d1049ef5cf9800a8c4d8ac354 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 195 | 27 | 3 | 359b9d791e26844675c3c60cf69d8ab69c2cf400 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, condition lineage and cell class | 2.20e-04 | 196 | 27 | 3 | 1611920211beb1a3691e3853e0314792a74279a0 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.20e-04 | 196 | 27 | 3 | b10810c6a2ad3d3b968bfef46a68a38e0ce31331 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4|blood / Manually curated celltypes from each tissue | 2.20e-04 | 196 | 27 | 3 | 05c2ad461a3c093ede4af677a61f9132e525e0b5 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.24e-04 | 197 | 27 | 3 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | (2)_NK/T-(221)_CD8+_Naive_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 2.24e-04 | 197 | 27 | 3 | 5943f30288d4c9a7d7ef2e85461487a229f44511 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.27e-04 | 198 | 27 | 3 | c4d8d133e571ad3a7c5de93aa7befb67cb7a003d | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, condition lineage and cell class | 2.31e-04 | 199 | 27 | 3 | 90ddd686b8f39c6f6134b9b048396cebcf8d0448 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B|Int-URO / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 9596e5f1a6cc7dfafc8d68ebd53ff32c41b06256 | |
| ToppCell | Sepsis-URO-Lymphocyte-B-B_naive|URO / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 0275c3f600e89c9700806642c8315de897f16a6d | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_naive|Int-URO / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | d2bf9792503fbe84f1dcac8c8ca02b504a07ab45 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_CD56bright|COVID-19_Severe / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 12626d046a3ed8db1c9bd603ada5b97ead93e587 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Glia_progenitor_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | 4b937b1d0179d1d0e51931f35720e205d460a07e | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.34e-04 | 200 | 27 | 3 | 5a4c79e18c1eb63cf359d3b3c4fb80bbf27645a5 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 221dd8d8851c47f2202ba848de3a041b17b1db3f | |
| Disease | retinal layer thickness measurement | 1.18e-03 | 60 | 25 | 2 | EFO_0600002 | |
| Disease | schizophrenia (is_implicated_in) | 1.99e-03 | 78 | 25 | 2 | DOID:5419 (is_implicated_in) | |
| Disease | spine bone mineral density | 4.55e-03 | 119 | 25 | 2 | EFO_0007701 | |
| Disease | verbal-numerical reasoning measurement | 5.49e-03 | 131 | 25 | 2 | EFO_0008394 | |
| Disease | peak expiratory flow | 8.34e-03 | 498 | 25 | 3 | EFO_0009718 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECGHAYSGIVAHQKH | 101 | Q9H2A7 | |
| KGIYLCGHSAGAHLA | 156 | Q63HM1 | |
| VIKGAHYICHSGGHC | 126 | Q13133 | |
| QVGCVHAGHKYAAGH | 136 | P98095 | |
| HLRTHSVGKPHKCGY | 191 | Q13422 | |
| HYHGKTKGQGDEGRH | 486 | Q9P0X4 | |
| LHVAAHCGHYKVAKV | 371 | Q12955 | |
| ICGSHGVEHRVYKHF | 126 | Q9NPI7 | |
| LKQIYGCSHEGKIHH | 1001 | Q9Y283 | |
| EGSYRIHVLHHGTGK | 511 | Q53GS9 | |
| CKKYGGVSHHQSHLF | 186 | Q7L1S5 | |
| CGKAFGKSKHLLQHH | 201 | Q14592 | |
| KHHRIHTGEKPYGCS | 486 | Q53GI3 | |
| VHTGIRYHICSHCGK | 131 | Q9C0F3 | |
| SRGLGKGHKFHHTIG | 171 | P61313 | |
| SVHCGRYVNGHAKKH | 46 | Q9Y6I4 | |
| CGKTFSRGYHLILHH | 371 | Q8N141 | |
| GHHRVHTGVKPYKCK | 281 | Q9H4T2 | |
| HHSSHGGRKRYACQG | 431 | Q8TBC5 | |
| LVCHHRLHGGEKSYK | 441 | Q8N823 | |
| GGLVDHNHHKGLTYK | 206 | Q8TBZ6 | |
| IHHQAIHGIGKLYKC | 386 | A6NHJ4 | |
| SHRGKTHYNCGEHTK | 126 | Q13106 | |
| HHVKGHGGTRLYKCT | 1441 | P52746 | |
| HHRLHGGEKSYKCKV | 376 | Q6ZNG1 | |
| GCGRLYTTAHHLKVH | 171 | P36508 | |
| CGKGYISKSGLDFHH | 346 | Q9UK12 |